CSI offers a comprehensive menu of both hematopoietic and solid tumor molecular assays for qualitative and quantitative analysis. Our advanced single gene testing, targeted profile molecular assays, and broad-spectrum tumor testing yield clinically actionable data for precise diagnosis and appropriate therapy selection. Our molecular testing services include:

  • A full range of NGS, real time PCR, fragment length analysis and Sanger sequencing
  • Comprehensive in-house hematopoietic and solid tumor test offerings
  • Single gene and full panel testing, plus customizable reflex panels
  • Enhanced microdissection for better sensitivity and fewer instances of QNS

Talk to your sales representative about this and other advantages CSI can provide to your organization.